28/06/2024 - AB Science SA: AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

The text version of this document is not available. You can access the original document here.

Attachments

• Original Link
• Permalink

Disclaimer

AB Science SA published this content on 28 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2024 10:47:04 UTC.